It is unclear whether there is a racial difference in the incidence of diabetic complications in underinsured populations.
tions, especially cardiovascular complications (5) (6) (7) , and studies that have made direct comparisons of the incidence of diabetic complications between African-American and white diabetic patients are very limited (2, 8) . Furthermore, apparently few studies have been conducted on lower-income and disadvantaged populations. The present study aims to test the hypothesis that racial disparities exist in the incidence of diabetic complications in AfricanAmerican and white diabetic patients within the Louisiana State University Hospital-Based Longitudinal Study (LSUHLS), the participants of which were mainly low income.
Materials and Methods

Subjects
The Louisiana State University Health Care Services Division (LSUHCSD) operates seven public hospitals and affiliated clinics in Louisiana, which provide quality medical care to the residents of Louisiana, regardless of their income or insurance coverage (9) . Overall, LSUHCSD facilities have served approximately 1.6 million patients (35% of the Louisiana population) since 1990. In the whole population served by the LSUHCSD hospitals, about 46% of patients qualify for free care (by virtue of being low income and uninsured, any individual or family unit whose income is at or below 200% of federal poverty level), approximately 10% of patients are self-pay (uninsured, but incomes not low enough to qualify for free care), approximately 20% of patients are covered by Medicaid, about 14% of patients have Medicare, and approximately 10% of patients are covered by commercial insurance (9 -12) .
Administrative, anthropometric, laboratory, and clinical diagnosis data collected at these facilities are available in electronic form since 1997 for both inpatients and outpatients. Using these data, we have established the LSUHLS. All patients' information on birth date, race, sex, address, types of insurance, family income, smoking habits, date of examination, measurements of height, weight and blood pressure for each clinical visit, diagnosis of various diseases and date of diagnosis, laboratory tests, and medication history was included in the LSUHLS database. A cohort of diabetic patients was identified through the LSUHLS database between January 1, 1997, and June 1, 2009. The first record of diabetes diagnosis was used to establish the baseline for each patient in the present analyses due to the design of the cohort study. A total of 93,165 subjects (24% non-Hispanic white women, 36% African-American women, 18% non-Hispanic white men, and 22% African-American men) between the ages of 30 and 96 yr were identified by using the International Classification of Disease, ninth revision (ICD-9) code 250. Both inpatients and outpatients were included and the majority patients in the present study are primary care patients. Since 1997, LSUHCSD's internal diabetes disease management guidelines call for physician confirmation of diabetes diagnoses by applying the American Diabetes Association criteria: a fasting plasma glucose level of 126 mg/dl or greater; 2-h glucose level of 200 mg/dl or greater after a 75-g, 2-h oral glucose tolerance test; one or more classic symptoms plus a random plasma glucose level of 200 mg/dl or greater (13) . These participants had benefited from LSUHCSD hospitals for 3.68 Ϯ 4.35 yr before the baseline. The study and analysis plan were approved by both the Pennington Biomedical Research Center and the LSU Health Sciences Center Institutional Review Boards and the LSU System. We do not obtain informed consent from all participants involved in our study because we use the electronic data set from medical records.
Baseline measurements
Patient characteristics, including age, race/ethnicity, family income, smoking status, weight, body mass index (BMI), blood pressure, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, glycosylated hemoglobin (HbA 1c ), estimated glomerular filtration (eGFR) rate, albumin, and medication (antihypertensive drug, cholesterol lowering drug, and antidiabetic drug) within 1 yr of the diabetes diagnosis were extracted from the computerized hospitalization records. Height was measured without shoes and weight was measured with light clothing. BMI was calculated by dividing weight in kilograms by the square of height in meters. Blood pressure was measured from the right arm after 5 min of sitting using a mercury sphygmomanometer or automatic blood pressure monitor.
Follow-up
Follow-up information was obtained from the LSUHLS database by using the unique number assigned to every patient who visits the LSUHCSD hospitals. The average number of clinic visits during the follow-up period was 27 for white diabetic patients and 26 for AfricanAmerican diabetic patients. Four diabetic complications were used as outcomes in this study, including CHD (ICD-9 codes 410-414), HF (ICD-9 codes 402.01, 402.11, 402.91, and 428), stroke (ICD-9 codes 430-436), and ESRD (ICD-9 codes 250.4, 403-404, 585, and 586). Since 1997, diagnoses of CHD, HF, stroke, and ESRD were made by the treating physicians, based on a clinical assessment and examinations as considered relevant by the clinician in charge of treatment. Follow-up of each cohort member continued until the date of the diagnosis of the outcome disease, the date of the last visit if the subject stopped use of LSUHCSD hospitals, or January 31, 2010 (9) (10) (11) (12) .
Statistical analyses
The age-adjusted (age and sex adjusted when men and women were combined) incidence rate was calculated by the direct method to the year 2010 Census population using the age groups 30 -39, 40 -49, 50 -59, 60 -69, and 70 yr or older. The incidence rates are presented as the number of events per 1000 person-years with 95% confidence interval (CI). Cox proportional hazards regression was used to estimate the association between race and the risk for each of the four outcome diseases. All proportionality assumptions were appropriate. All the above analyses were first carried out adjusting for age (age adjusted model) and further for smoking, income, BMI, systolic blood pressure, diabetes type, HbA1c, LDL cholesterol, triglycerides, eGFR, albumin, use of antihypertensive drugs, use of diabetes medications, and use of cholesterol-lowering agents (multivariate adjusted model). The age-adjusted model was based on all the study participants. Because not all study participants had the relevant information, the multiple-imputation method was used to replace the missing variables. The Markov Chain Monte Carlo method was used to impute all missing values to make 10 complete data sets (Proc MI). After the 10 complete data sets were analyzed using Proc Phreg, the Proc MIANALYZE procedure was used to generate valid statistical inferences by combining results from the 10 analyses. In addition, another multivariate-adjusted model was built based on the study participants who had complete relevant information (sensitivity analysis). Statistical significance was considered to be P Ͻ 0.05. All statistical analyses were performed by using SAS for Windows, version 9.3 (SAS Institute, Cary, NC).
Results
The present study included 93,165 diabetic patients (24% white women, 36% African-American women, 18% white men, and 22% African-American men) with a mean follow-up of 4.4 yr. General characteristics of the study population at baseline are presented by race and sex in Table 1 . White subjects were generally older and had higher BMI, total cholesterol, triglycerides, albumin, cholesterol-lowering medication usage, and higher portion of current smokers when compared with African-American subjects. African-American subjects had higher blood pressure, HDL and LDL cholesterol, HbA 1c , antihypertensive drug usage, and antidiabetic drug usage. Analyses were based on subjects with the target information. Values are adjusted for age. GFR, Glomerular filtration rate.
During follow-up, 16,935 participants (25% white women, 33% African-American women, 23% white men, and 19% African-American men) developed CHD. Unadjusted and adjusted incidence rates of CHD were lower in women than in men for both races. White participants had higher unadjusted and age-adjusted incidence rates when compared with African-Americans ( Table 2 ). Relative to African-Americans, whites had a 51% increased risk for CHD when adjusted for age and sex. Further adjustment for other factors only slightly changed the hazard ratio (HR) ( Table 3) . Sensitivity analysis gave similar results.
There were 13,421 new cases (23% white women, 36% African-American women, 20% white men, and 21% African American men) of HF during follow-up. Unadjusted and adjusted incidence rates of HF were lower in women relative to men across both races. When men and women were combined, the age-and sex-adjusted incidence rates were 48.0 per 1000 person-years (95% CI 46.6 -49.4) in whites and 40.7 per 1000 person-years (95% CI 39.6 -41.8) in African-Americans ( Table 2 ). The multivariateadjusted HR based on the whole study sample was 1.24 (95% CI 1.19 -1.29) for whites when compared with African-Americans. Sensitivity analysis showed similar results (Table 3) .
A total of 6804 subjects (24% white women, 36% African-American women, 19% white men, and 21% African-American men) had stroke diagnoses during followup. Unadjusted and adjusted incidence rates of stroke were lower in women than in men for both races. Relative to African-Americans, whites had a 12% higher age-and sex-adjusted incidence rate of stroke ( Table 2 ). The multivariate-adjusted HR based on the whole study sample was 1.16 (95% CI 1.10 -1.22) for whites relative to African-Americans. The sensitivity analysis yielded higher HRs (Table 3) .
There were 5355 individuals (21% white women, 37% African-American women, 16% white men, and 26% African-American men) who experienced a first ESRD during follow-up. Similarly, unadjusted and adjusted incidence rates of ESRD were lower in women than in men for both races. However, whites experienced lower ESRD incidence rates relative to African-Americans. The age-and sex-adjusted incidence rates were 17.3 per 1000 personyears (95% CI 16.6 -18.0) in African-Americans and 15.1 per 1000 person-years (95% CI 14.3-15.8) in whites (Table 2). In both age-adjusted and the multivariable-adjusted analyses, white men had a significantly lower risk of ESRD than African-American men. However, no significant associations were observed in women and in men and women combined in the multivariable-adjusted analyses (Table 3) . When men and women were combined, whites had significantly lower risk of ESRD than that of AfricanAmericans in the age-adjusted model. After further adjustment for other confounding factors, this association was not significant anymore. Sensitivity analysis gave slightly different results (Table 3) .
Discussion
The present study, involving 93,165 diabetic participants, is a large-scale investigation of the incidence of diabetic complications in a biracial population of low-income individuals. Our study suggested that, among diabetic patients who received medical care from the LSUHCSD hospitals, African-American diabetic patients experienced higher rates of ESRD yet lower rates of CHD, HF, and stroke than white diabetic patients. Female diabetic patients had lower incidence rates of the four complications than male diabetic patients. The results support the existence of race and sex disparities in the incidence of diabetic complications in this population. Very limited studies have examined incidence of ESRD and cardiovascular complications among diabetic patients from different races. Even fewer studies compared the difference between African-Americans and whites (5, 8, 14 -16) . More than 2 decades ago, a report (5) from the Michigan Kidney Registry found a 2.6-fold higher incidence of ESRD among African-Americans with diabetes than among whites with diabetes after adjustment for the higher prevalence of diabetes among African-Americans. In Maryland, an excess incidence of diabetic ESRD in African-Americans was also reported (14) . Kaiser Permanente Medical Care Program (8) again reported a higher incident rate of ESRD among African-Americans with diabetes. However, two studies (15, 16) did not find a significantly different risk of diabetic ESRD between AfricanAmericans and whites. To date, only two studies have compared the prevalence/incidence of cardiovascular diabetic complications between African American and white diabetic patients. Prevalence did not differ significantly by race in one study (15) , whereas in the Kaiser Permanente Medical Care Program, a significantly higher risk of myocardial infarction was reported among white diabetic patients but not in stroke and congestive heart failure (8).
In the current study, significant racial disparities in the four reported diabetic complications were found, and the incidence rates of the four reported diabetic complications were higher than those in the past studies. Compared with the previous studies, the current study has a larger diabetic cohort, especially African-Americans, which may have more statistical power to identify the underlying difference. According to the Department of Health and Hospitals of Louisiana, the population in Louisiana has high prevalence of physical inactivity, overweight/obesity (Louisiana has the fourth highest rate of adult obesity) (17) , high blood cholesterol, high blood pressure, tobacco use, and poor nutrition (Louisiana Department of Health and Hospitals, http://new.dhh.louisiana.gov/assets/oph/ pcrh/heartdisease/HDSPStatePlan_FINAL.pdf). All these factors may contribute to the higher diabetic complication incidence in Louisiana. In addition, the higher frequency of no insurance (free of charge and self-pay) of the participants in our study may also play a role in the higher incidence of the diabetic complications (19) . One study (20) suggested that even in an insured population with good access to health care, socioeconomic circumstances remained an important predictor of health. Health care quality, health care access, patient self-care practices, and inherent biological and genetic factors may contribute to the racial heterogeneity identified in these studies (5, 8, 14, 15) . Hypertension, diabetes, hyperlipidemia, obesity, and smoking have been found to be important vascular risk factors for CHD, HF, and stroke (17, 21, 22) . African-Americans have a higher prevalence of obesity, diabetes, and hypertension in the general population, which may contribute to the higher mortality rates from cardiovascular diseases and diabetes among AfricanAmericans than white Americans (17, 23) . However, in diabetic patients, as demonstrated in our study and other studies, the significant differences in the prevalence of obesity and hypertension decreased or disappeared (7, 8) . In addition, a previous study showed that African-Americans had better levels of lipid and lipoprotein than whites (24) . In the current study, although the mean values of blood pressure and HbA 1c were slightly higher in AfricanAmericans than in whites, the lower prevalence of obesity, the better levels of lipids, the lower mean values of albumin, the lower prevalence of smoking, and the higher prevalence of using antihypertensive medicine may result in the lower incident rates of CHD, HF, and stroke among African-Americans diabetic patients as compared with white diabetic patients. Brancati et al. (14) suggested that the higher incidence rate of ESRD may be explained by a higher prevalence of diabetes or hypertension and an increased susceptibility to ESRD resulting from type 2 diabetes among African-Americans as compared with whites. This might account for the higher incidence rate of ESRD in African-Americans than in whites in the current study (9) . Furthermore, the influence from health care quality and health care access may be minimized in our study because of the following: 1) the participants used the same public health care system, 2) the percentage of white diabetics and African-Americans who were free of charge and self-pay are almost the same, and 3) the frequency of clinical visits during follow-up for white diabetics and African-Americans are very similar.
The reason for the sex disparity we have observed in the incident rates of the four diabetic complications is unclear.
The results are in keeping with the finding that mortality rates were higher for diabetic men than for diabetic women in the First National Health and Nutrition Examination Survey and other studies (3) . Although several studies have showed that women with diabetes had worse LDL control and blood pressure control than men with diabetes (25, 26) , and women were significantly less likely than men to have received the recommended process measures for diabetes, such as HbA1c testing, lipid profile, urine microalbumin/protein testing, eye examinations, foot examinations, and influenza vaccination (27, 28) , a recent study found a positive association of female sex with HbA 1c control, with women being more likely to be at or below HbA 1c less than 8% target levels than men (29) . In the current study, women had a lower HbA1c level than men and are more likely on medication, which might have partly accounted for the lower incident rates of the four diabetic complications in women than in men.
Hurricane Katrina, which hit New Orleans in 2005, greatly disrupted the health systems in Louisiana (30 (11) . Because Katrina decimated the health care infrastructure, led to partially or completely lost in medical supplies and medication, interrupt the normal regimen of people affected by this disaster, we could expect that diabetics experienced poor management after Katrina. This may partly contribute to the higher rates of diabetic complications in our study (30) . However, the impact of Katrina on the sex and race disparity observed in this study might be small because participants were mainly from the same socioeconomic class. In addition, two of the seven hospitals operated by LSUHCSD are located in New Orleans, and the other five are located in five other cities including Baton Rouge, which were major routes for evacuation in the aftermath of Hurricane Katrina.
There are several strengths in our study, including the large sample size, high proportion of African-Americans, long follow-up time, and the use of administrative databases to avoid the problem of differential recall bias. In addition, participants in this study use the same public health care system, which minimizes the influence from the accessibility of health care, particularly in comparing African-Americans and whites. One limitation of our study is that our analysis was not performed on a representative sample of the state of Louisiana's population, which limits the generalizability of this study; however, LSUHCSD hospitals are public hospitals and cover more than 1.6 million patients, most of which were low-income persons in Louisiana. Nevertheless, the present study used a cohort study design and reported both the unadjusted and the adjusted incidence rates for four major diabetic complications in participants who received medical care from Louisiana public hospitals, which provides important information for understanding the scope and burden of diabetic complications in Louisiana, especially those on low income. Second, even though our analyses were adjusted for an extensive set of confounding factors, residual confounding due to the measurement error in the assessment of confounding factors, unmeasured factors such as physical activity, education, dietary factors, and family history of diabetes and other chronic diseases cannot be excluded. Third, deaths were not included in the outcome definition. However, this is most probably not systematically related to the outcome because each cohort member was followed up until the date of the diagnosis of the outcome or the date of the last visit. Fourth, ascertainment of CHD, HF, stroke, and ESRD status was based on the hospital discharge register. Although we did not conduct a validation study of the main outcomes in our LSUHCSD hospitals, the method of using the hospital discharge register to diagnose the major nonfatal diseases has been widely used in American cohort studies, such as the Kaiser Permanente Medical Care Program (7, 8) , the Framingham Offspring Study (18) , etc. The validity of the diagnoses of myocardial infarction, stroke, and HF by using hospital discharge register in these cohort studies is high (8) .
In conclusion, the current study suggests that heterogeneity of diabetes outcomes exists in different races in the underinsured population. The results from the current study must be confirmed from population-based studies. The impact of poverty on these adverse outcomes also must be better understood and addressed.
